After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Nurix Therapeutics Inc is $745.58M. A total of 0.64 million shares were traded on the day, compared to an average of 999.10K shares.
In the most recent transaction, van Houte Hans sold 6,198 shares of NRIX for 11.33 per share on May 02 ’25. After the transaction, the Chief Financial Officer now owns 33,724 company shares. In a previous transaction on May 02 ’25, JOHANNES VAN HOUTE bought 6,198 shares at 11.16 per share.
Among the insiders who sold shares, Hansen Gwenn disposed of 3,377 shares on Apr 30 ’25 at a per-share price of $11.50. This resulted in the Chief Scientific Officer holding 61,516 shares of NRIX after the transaction. In another insider transaction, Ring Christine sold 2,894 shares at $11.50 per share on Apr 30 ’25. Company shares held by the Chief Legal Officer now total 37,318.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, NRIX has a high of $29.56 and a low of $8.18.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. NRIX’s latest balance sheet shows that the firm has $295.72M in Cash & Short Term Investments as of fiscal 2021. There were $13.04M in debt and $66.26M in liabilities at the time. Its Book Value Per Share was $6.31, while its Total Shareholder’s Equity was $342.30M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
